Hi Windshift - I can't disagree that vaccines and drugs are...

Hi Windshift - I can't disagree that vaccines and drugs are different - nor that Merck is gargantuan and different parts have different priorities on them.

So I guess that a Merck bid for VLA means nothing of consequence - either good or bad - for its relationship and interest in BNO.

I still reckon that since the company is chronically undervalued if you believe the talk, then they really should just ask Merck for a bid.

A bid at $500m would equate to a tad over a dollar a share.

Most of us would be drunk for a week if they delivered that outcome.

Bring it on.

The higher valuations hypothesized by Wainright and Shaw and Bell Potter are all well and good but based on probabilities that are extremely subjective.

Management don't have a clue what the company is worth - I have asked them - and they just look back with blank stares.

Yes, amazing that the value of the company is a mystery.

It begs the question of what any asset in the Balance Sheet is valued at.

Perhaps the skinny asset values in the Balance Sheet do in fact reflect the Boards considered valuation on all of the assets - after all it is supposed to be market value or an estimate thereof...........

The reason they do not have a view is because it would highlight either that they do not believe that they have much of value - or it would highlight that they can't get the value recognised in the market place and therefore they have let shareholders down by allowing the stock to trade below fair value.

The CEO would then be required to walk the plank as the undervaluation would be a KPI that any self respecting Board would expect any half decent CEO to address.

Anyway we sit and wait and hope and pray.......

......just like Malcolm and Barnaby hoping that their circumstances will magically change too.